Wed, Jul 23, 2014, 4:25 AM EDT - U.S. Markets open in 5 hrs 5 mins

Recent

% | $
Click the to save as a favorite.

ProShares UltraShort S&P500 Message Board

stevenjay1959 14 posts  |  Last Activity: Jul 15, 2014 7:29 AM Member since: Dec 31, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • stevenjay1959 by stevenjay1959 Jul 15, 2014 7:29 AM Flag

    Short all the way down to .065. announce a reverse split of 1-50. Open it at 1.15 or over .026 and then........here it comes-a financing at a 1.00 or .02 pre- reverse. Everyone makes money but the investor. That's my prediction. This stock will probably be halted.

  • Reply to

    A Mess

    by stevenjay1959 Jul 9, 2014 8:00 AM
    stevenjay1959 stevenjay1959 Jul 9, 2014 8:30 PM Flag

    ok lowlife with no brains

  • stevenjay1959 by stevenjay1959 Jul 9, 2014 8:00 AM Flag

    Someone at work told me about this stock at .18. Glad I didn't buy it. Just read their financials. Constant dilution. Constant revising of debentures to lower levels-constant dilution and major cash burn rate. They even lease space from company principals.I would expect a large reverse split, more dilution.

  • The article is very positive but its assumption of an acceptable buyout price is way too low. It doesn't factor in the new acquisition and the other applications being developed for heart related maladies. Plus, if MSTX was on the verge of developing an approved drug for a 1 billion dollar industry why would they sell out at a paltry 1.16? They wouldn't. I would think that 3-5.00 would be closer to the price.

  • stevenjay1959 by stevenjay1959 Jun 15, 2014 10:06 AM Flag

    I find it intriguing that Jack Lief, a founder of that company sits on the board of MSTX.. Thoughts?

  • Reply to

    Baker Brothers

    by stevenjay1959 May 27, 2014 2:23 PM
    stevenjay1959 stevenjay1959 May 27, 2014 4:32 PM Flag

    yes. Go to NASDAQ website type in mstx and then hit institutional holdings

  • stevenjay1959 by stevenjay1959 May 27, 2014 2:27 PM Flag

    I don't post often but I know that there are some astute investors on this board and some not so much. I will reiterate that I am a beliver in Ino but not a fan of the reverse split. I think that benefits the institutions more so than us the small investors. My question is about mstx. I read a filing that the Baker Brothers just bought 3 million shares. Any idea on why they would take a position in such a small biotech?

  • stevenjay1959 by stevenjay1959 May 27, 2014 2:23 PM Flag

    Looked at their holdings and am somewhat surprised that they bought 3 million shares of mstx. I own mstx and believe that the stock is going to trade much higher. Any thoughts on the motives behind the Baker Brother's position?

  • stevenjay1959 by stevenjay1959 May 21, 2014 7:40 AM Flag

    Where do you see a position for Fresenius and how many shares? What are your thoughts on the 28 million warrants at .65 overhanging the market?

  • stevenjay1959 by stevenjay1959 May 12, 2014 12:16 PM Flag

    Reverse split reduces shares to higher levels. It also reduces the short position of 29 million shares. After the phase II is successful INO will begin the very costly phase III clinicals. The average short position price is most likely north of the 2.90 funding. In the future, probably end of this year INO will announce a large secondary offering of 100 million plus. This will effectively fund the phase III clinicals amongst other undertakings. We will be diluted but buy serious institutional investors. Look for a large firm like Morgan Stanley to take over the ball at that point. The reverse split I would assume was orchestrated by Wall Street and not INO.

  • stevenjay1959 by stevenjay1959 May 7, 2014 7:28 AM Flag

    Makes great points. The bottom line is either INO's technology works or it doesn't. If it does work then a $10,000 investment will easily be worth $300,000 + That kind of money will change some people's lives. If it doesn't work a loss of 7-$,8000 is the downside.

    I say with all the smart money investing in INO-with all the scientific experts validating the company and its science, including Roche, INO is a very well calculated investment. Sometimes even the longs, including me can be rattled by a selloff but as NOTABADPICKER points out-patience will be rewarded.

  • stevenjay1959 by stevenjay1959 May 3, 2014 9:19 AM Flag

    Funny how he illustrates all the wonderful aspects of oncs BUT FAILS to disclose that they just filed a highly dilutive registration statement for $75 million dollars + warrants.

  • Reply to

    REVERSE SPLIT

    by stevenjay1959 May 1, 2014 9:25 AM
    stevenjay1959 stevenjay1959 May 1, 2014 9:41 AM Flag

    I am long. Not sure what you are referring to. Just making sense of the logic behind the revers split.

  • stevenjay1959 by stevenjay1959 May 1, 2014 9:25 AM Flag

    You have to think as investment firms do. These are the players funding ino. They advise and this is most likely what the issues are. The stock was literally below .50 There are roughly 200 million shares out and many in the hands of shareholders at lower price points. INO will need additional funding for completion of their clinicals.Reduce the shares, which makes the whole shares outstanding more manageable. They know more shares are going to be issued after the reverse split-maybe not immediately, but down the road. The recent 60 million dollar equity raise can only go so far. Obviously with the recent purchase of huge square footage and hires Dr. Kim is not looking for a buyout. There may be additional funds from strategic partners but ultimately it is the Wall Street firms, who believe that INO is the real deal, who will take the stock from 5 to 100+

SDS
24.76-0.22(-0.88%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.